Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof Grant US-11925617-B2 United States of America 12 Mar 2024
Compositions and methods for parenteral administration of therapeutic agents Grant US-11744859-B2 United States of America 05 Sep 2023
Treatment of gliomas using organonitro compound combination therapy Grant US-11701351-B2 United States of America 18 Jul 2023
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical… Grant US-11660286-B2 United States of America 30 May 2023
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Grant US-11649242-B2 United States of America 16 May 2023
Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1… Grant US-11576895-B2 United States of America 14 Feb 2023
Methods and compositions utilizing RRx-001 combination therapy for radioprotection Grant US-11510901-B2 United States of America 29 Nov 2022
Compositions for activating pyruvate kinase Grant US-11396513-B2 United States of America 26 Jul 2022
Treatment of brain metastases using organonitro compound combination therapy Grant US-11160784-B1 United States of America 02 Nov 2021
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Grant US-11014927-B2 United States of America 25 May 2021
Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in… Grant US-11008287-B2 United States of America 18 May 2021
Activating pyruvate kinase R and mutants thereof Grant US-11001588-B2 United States of America 11 May 2021
Compositions for activating pyruvate kinase Grant US-10836771-B2 United States of America 17 Nov 2020
Treatment of gliomas using organonitro compound combination therapy Application US-10543208-B2 United States of America 28 Jan 2020
Compositions for activating pyruvate kinase Grant US-10472371-B2 United States of America 12 Nov 2019
Compositions for activating pyruvate kinase Grant US-10208052-B1 United States of America 19 Feb 2019